Series A Therapeutics Companies

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.

Holoclara is a immunotherapy company that offers autoimmune disorders with nematode derived molecules.

Broad-spectrum antiviral drug development

Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

Uniting science and technology to end silent suffering in Urology with accessible, reimbursable digital care

Asgard Therapeutics is a Biotechnology Company.

Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.

Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.

Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

Ciba Health offers a personalized digital therapeutics and virtual care platform.

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.